Announcement of launch, break or close-out of marketing of a medicinal product

The database includes reports since 31st December 2007, date of effect of the Act No 378/2007 Coll., stipulating the obligation of marketing authorisation holders to report launch, suspension or withdrawal from the market of a medicinal product to SÚKL

Search

 

   

   

Number of records: 4
SÚKL code Name of medicinal product Supplement of name Type of announcement Effective date Alternate medicines 1)
Reason for interruption/cessation of marketing Reason for interruption/cessation of marketing
0226453 URSOSAN FORTE 500MG TBL FLM 100 Placing on the market 12.04.2018
0097864 URSOSAN 250MG CPS DUR 50 I Placing on the market 01.09.2015
0097864 URSOSAN 250MG CPS DUR 50 I Cessation of marketing 08.07.2011 0013808, 0091017
0097864 URSOSAN 250MG CPS DUR 50 I Interruption of marketing 08.07.2011 0013808, 0091017
1) The review shows only medicinal products with active incidence on the Czech market (based on regular reports of supplies of distributed human medicinal products in the previous quarter).

Medicinal products reimbursed from health insurance are marked in color.
Last database update: 23. April 2019 v 02:05